CNO Financial Group Set to Join the S&P MidCap 400 |
April 02, 2015 | April 2015 Bond Updates |
NEW YORK, April 1, 2015 /PRNewswire/ -- CNO Financial Group (NYSE: CNO) will replace Salix Pharmaceuticals (NASD: SLXP) in the S&P MidCap 400 after the close of trading on Monday, April 6. Valeant Pharmaceuticals (NYSE: VRX) completed the acquisition of Salix Pharmaceuticals... |
View more at: http://www.prnewswire.com/news-releases/cno-financial-group-set-to-join-the-sp-midcap-400-300059792.html |
Related News |
|